NEW YORK (MarketWatch) -- Valeant Pharmaceuticals International Inc. (VRX) said Thursday it has filed an official and detailed complaint with the Canadian regulator, Autorite des Marches Financiers, about statements made by Allergan Inc. (AGN) regarding Valeant's business.
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements Canada NewsWire
LAVAL, Quebec , July 24, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: AGN) apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements correcting this misinformation.
LAVAL, Quebec , July 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: AGN) apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements correcting this misinformation.
GLASGOW, Scotland , July 24, 2014 /PRNewswire/ -- Cancer patients in the west of Scotland will gain access to state-of-the-art cancer treatment closer to home when a new radiotherapy center opens near Glasgow next year.
Revenue from continuing operations for the second quarter of 2014 was $47.7 million, an increase of 28% compared to the second quarter of 2013; Operating income from continuing operations for the second quarter of 2014 was $7.6 million, an increase of 297% compared to the second quarter of 2013.
Inc. (NASDAQ: WOOF) , a leading animal healthcare company
in the United States and Canada, today reported financial results for
the second quarter ended June 30, 2014, as follows: revenue increased
5.2% to a second quarter record of $489.5 million; gross profit
increased 5.4% to $120.4 million; operating income increased 5.6% to
$79.9 million; net income increased 9.4% to $45.6 million and diluted
earnings per common share increased 10.9% to $0.51. Non-GAAP earnings
per diluted common share excluding acquisition-related amortization
("Adjusted EPS Excluding Amortization") increased 10.0% to $0.55 for the
three months ended June 30, 2014.
SAN DIEGO, July 24, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and six months ended June 30, 2014, before the opening of trading on Thursday, July 31, and conduct a conference call and webcast to discuss the financial results and provide a company update at noon Eastern Time on Thursday, July 31.
Waters Corporation (NYSE:WAT) today announced VICAM ® , A Waters ®
Business, received USDA-GIPSA (Grain Inspection, Packers & Stockyards
Administration) certification for its Afla-V™
lateral flow strip test for the quantitative analysis of total
aflatoxins in corn.
Visa Inc. (NYSE:V), the global leader in payments, today announced the
creation of Visa Digital Solutions, a comprehensive suite of offerings
that facilitate secure payments across a broad range of
Internet-connected devices and wearables.
Orangeburg, NY, July 24, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) , a leading provider of
unique flexible endoscopic products utilizing its proprietary
sterile disposable EndoSheath® technology, today announced that the
Company will release its financial results for the first quarter
fiscal 2015, ended June 30, 2014, after the market closes on
Monday, August 4, 2014.
TORONTO, ON--(Marketwired - July 24, 2014) - ViXS Systems Inc. (TSX: VXS), a pioneer and leader in media processing solutions, is pleased to announce that semiconductor veteran Michael Economy has joined as Vice President, Strategic Accounts, with a primary focus on pay television service providers.
Award Winning M100 Gains Direct Access To Mainland China Through Relationship with World's Largest PC Manufacturer ROCHESTER, N.Y. , July 24, 2014 /PRNewswire/ -- Vuzix Corporation (OTC:QB: VUZI) ("Vuzix" or, the "Company"), a leading supplier of Video Eyewear and smart glasses products in the consumer, commercial and entertainment markets, is pleased to announce that it has signed a major deal with Lenovo, the world's largest PC company to launch the award-winning M100 Smart Glasses into China .
Sign-up for Walgreens President of Pharmacy, Health and Wellness Kermit Crawford Announces Retirement from Company after 31 Years; Will Continue to Serve as Senior Counselor to Walgreens President and CEO investment picks
Today, Walmart (NYSE: WMT) announced that Greg Foran, 53, has been
promoted to President and CEO of Walmart U.S. Foran succeeds Bill Simon
who has been in the role since June 2010 and will be transitioning out
of the company.
NEW YORK, July 24, 2014 (GLOBE NEWSWIRE) -- Warren Resources, Inc. (Nasdaq:WRES) ("Warren" or the "Issuer") announced today that it intends to commence a private offering to eligible purchasers of $300 million aggregate principal amount of Senior Notes due 2022 (the "Notes"). The Issuer intends to use the net proceeds from the offering to fund a portion of the approximately $312.5 million cash purchase price for its recently announced acquisition of the Marcellus assets of Citrus Energy Corporation and two additional working interest owners.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.